INTERNATIONAL JOURNAL OF ONCOLOGY
·
2026
·Vol. 69
·期 4
·1-23
·
IF 7.3
Tao Pan,Zujian Feng,Ting Shang,Jun Jiang,Fang Zhang
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
✓ 已验证
产品关联
DOI
高影响因子
International Journal of Peptide Research and Therapeutics
·
2026
·Vol. 32
·期 5
·81
·
IF 2.5
Zhang Miao,Wang Zhicheng,Li Liangbin,Liu Haiyang,Han Jiarun,Wu Zhen,Pan Daodong,Zhang Tao,Liu Hui,Tu Maolin
Purpose This research aims to identify novel antimicrobial peptides (AMPs) from casein, subsequently conducting an in-depth exploration of their antibacterial mechanism of action. Methods Casein was hydrolyzed by pepsin and fractionated via ultrafiltration, and the peptides were identified using Nano-LC-MS/MS. Then, the candidate antimicrobial peptides were screened based on in silico analysis of their antimicrobial potential, net charge, and solubility. The minimum inhibitory concentration (MIC) against E. coli ATCC 25922 was determined, and killing kinetics was analyzed. The effect on bacterial membrane integrity was assessed through the analysis of nucleic acid leakage, outer membrane permeability, inner membrane permeability, and cell membrane damage. Preliminary safety was evaluated via hemolytic activity and impact on L. acidophilus CICC 6074 and L. reuteri DSM 17938 growth. Results Two peptides, VRYL and RYL, were successfully identified from bovine casein hydrolysate. Both demonstrated potent inhibitory activity against E. coli ATCC 25922. VRYL exhibited a MIC of 3.5 mg/mL, which was lower than RYL’s MIC of 5.5 mg/mL. This indicates that VRYL possesses stronger inhibitory activity against E. coli compared to RYL. The antimicrobial mechanism of VRYL was analyzed and revealed that it exerts its antimicrobial activity by compromising the integrity of both the outer and inner bacterial membranes. Furthermore, VRYL exhibited favorable preliminary safety with no observable significant hemolytic activity. Conclusion The peptide VRYL possesses high antimicrobial activity and favorable preliminary safety characteristics. These findings suggest that VRYL holds substantial promise for utilization in the food industry and as a natural antimicrobial agent.
✓ 已验证
产品关联
DOI
高影响因子
CELLULOSE
·
2026
·
IF 4.6
Wang Qianqian,Zhong Lin,Wang Xinyu,Zhou Yang,Ummer Khadija,Liu Jun,Liu Huan,Zhu Qianqian
Gallium-based liquid metals possess high electrical conductivity and fluidity, but their enormous surface tension makes it difficult to disperse them uniformly in aqueous media. In this work, five types of nanocellulose, namely, cellulose nanocrystals (CNCs), cellulose nanofibrils (CNFs), TEMPO‑oxidized cellulose nanofibrils (TCNFs), quaternized cellulose nanofibrils (QCNFs), and bacterial cellulose (BC), were compared as interfacial stabilizers for gallium liquid metal (LM) Pickering emulsions. The nanocellulose/liquid metal Pickering emulsions were prepared by probe ultrasonication and characterized by optical microscopy, dynamic light scattering/zeta potential, TEM, FTIR, XPS, and TGA. All nanocellulose/liquid metal droplets formed core–shell structures, suppressing droplet coalescence. The stability of nanocellulose stabilized liquid metal Pickering emulsions followed the order BC > TCNFs > CNFs > QCNFs > CNCs. XPS analyses revealed that functional groups on nanocellulose interact with the gallium oxide skin via electrostatic attraction and coordination, and TGA indicated that the composites maintain good thermal stability and form gallium oxide at high temperatures. These results demonstrate that renewable nanocellulose can serve as green and effective stabilizers for high‑surface‑energy liquid metal, enabling long‑term stable Pickering emulsions. Graphical abstract
✓ 已验证
产品关联
DOI
高影响因子
npj Science of Food
·
2026
·
IF 9.7
Yang Zhenglei,Wu Yangmeixue,Liu Jun,Yang Yang,Fu Shuang,Hu Hongbo,Yin Shutao
Selenium (Se) is an essential micronutrient for human health; however, the efficient conversion of inorganic Se into organic forms remains challenging. Microalgae have emerged as promising platforms for sustainable production of functional food ingredients due to their rapid growth, metabolic versatility, and capacity to accumulate bioactive compounds. Here, Auxenochlorella pyrenoidosa ZC-1006 was evaluated as a heterotrophic platform for producing Se-enriched biomass. The most favorable heterotrophic conditions within the tested ranges were 15 g/L glucose, 2 g/L urea, an initial pH of 6.0, and cultivation at 31 °C. Supplementation with 5 mg/L sodium selenite (Na 2 SeO 3 ) provided a favorable balance between biomass accumulation and Se enrichment, yielding 108.74 mg/kg total Se on a dry weight (DW) basis. Ion chromatography–inductively coupled plasma mass spectrometry (IC–ICP-MS) analysis showed that organic Se accounted for 95.97% of the measured Se, with selenomethionine (SeMet) and selenocystine (SeCys 2 ) as the predominant identified species. Independent fermentation experiments conducted in 5 L and 3000 L systems further supported the technical feasibility of producing Se-enriched ZC-1006 biomass under the tested conditions. Transcriptomic analysis identified Se-associated expression changes in pathways related to sulfur-containing amino acid metabolism, glutathione metabolism, and antioxidant defense, while quantitative real-time polymerase chain reaction (qRT-PCR) supported selected transcript-level trends. These findings support A. pyrenoidosa ZC-1006 as a candidate platform for producing Se-enriched biomass, and the resulting biomass as a promising food-oriented ingredient for future food product development.
✓ 已验证
产品关联
DOI
高影响因子
JOURNAL OF NANOBIOTECHNOLOGY
·
2026
·
IF 15
Deng Xu,Xie Xixiang,Zhou Xing,Jiang Lanfang,Zhu Tao,Su Rixiang,Chen Chunmei,Chen Wan,Chen Chunxia
The therapeutic efficacy of ischemic stroke (IS) treatment is severely limited by insufficient accumulation of therapeutic agents within ischemic lesions and persistent secondary injury after ischemia–reperfusion. Herein, we report a cRGD-functionalized exosome-based nanoplatform that enhances ischemic lesion-associated accumulation and antioxidative neuroprotection for the treatment of IS. Neural stem cell-derived exosomes were functionalized with cyclic RGD peptides (cRGD) and subsequently loaded with Mn₃O₄ nanoparticles to construct a hybrid nanosystem (cRGD-Exo@Mn₃O₄). The engineered exosomes preserve intrinsic brain tropism, while cRGD modification promotes preferential accumulation in ischemic regions, potentially through interaction with α v β 3 integrin that is upregulated in ischemic lesions. The incorporated Mn₃O₄ nanoparticles confer robust reactive oxygen species (ROS) scavenging capability, thereby mitigating oxidative stress in ischemic microenvironments. In vitro and in vivo studies demonstrate that cRGD-Exo@Mn₃O₄ exhibits enhanced accumulation in ischemic regions compared with non-modified counterparts. The nanosystem effectively attenuates oxidative stress and neuroinflammation, leading to reduced infarct volume, alleviation of cerebral edema, and improved neurological function in MCAO/R mice. Mechanistically, transcriptomic analysis suggests that the therapeutic effects are associated with modulation of inflammation-and cell death-related pathways, including suppression of the RIPK1/RIPK3/MLKL signaling cascade. Collectively, this study presents a rationally designed exosome-based nanoplatform integrating ischemic lesion-associated accumulation with ROS-scavenging capability. Graphical abstract
✓ 已验证
产品关联
DOI
高影响因子
International Journal of Peptide Research and Therapeutics
·
2026
·Vol. 32
·期 5
·80
·
IF 2.5
Jiang Xinyi,Li Junxiang,Lu Yi,Ni Fangyuan,Li Sen
Purpose Advanced glycation end products (AGEs) and their downstream inflammatory consequences contribute to skin dysfunction and aging-related deterioration. EQ-9 has been identified as a novel functional peptide with anti-aging and skin repair potential. In this study, we investigated the effects of EQ-9 and its two derivatives (EL-6 and ac EL-6) on Methylglyoxal (MGO)-induced glycation and inflammatory damage. Methods We exposed HaCaT cells to MGO to simulate hyperglycemic conditions. The protective effects of these peptides were assessed through measurements of cell viability, migration, CML levels, inflammatory cytokine secretion, RAGE expression, and NF-κB pathway activation. Additionally, TNF-α/IFN-γ were used to induce inflammatory injury and evaluate the anti-inflammatory effectiveness of the peptides. A murine excision wound model was also established to examine the effects of ac EL-6 on skin inflammation, collagen deposition, angiogenesis, and wound healing. Results All three peptides significantly reduced MGO-induced CML generation, downregulated RAGE, inhibited NF-κB activation, attenuated proinflammatory cytokine secretion, alleviated cell damage, and promoted migration. They also mitigated TNF-α/IFN-γ-evoked inflammatory responses via NF-κB suppression. Topical application of ac EL-6 decreased cytokine levels, increased VEGF expression and collagen deposition, and consequently accelerated wound healing in mice. Conclusion Together, these findings identify ac EL-6 as a stabilized lead candidate derived from EQ-9, which exhibits anti-glycation activity and modulates NF-κB-mediated inflammatory signaling in keratinocytes, and demonstrates initial skin-repair potential in vivo. The data support further development of ac EL-6 for skin-directed applications. Graphical
✓ 已验证
产品关联
DOI
高影响因子
JOURNAL OF NANOBIOTECHNOLOGY
·
2026
·
IF 15
Yu Rongjun,Wu Jiangling,Chen Anyi,Xue Jianjiang,Guo Sihan,Chen Siling,Dong Shanshan,Li Li,Gui Xiao,Wang LiLin,Tian Gang,Liu Gang,Qiu Jingfu,Chen Weixian
Sepsis immunoparalysis (SIs) is a major factor contributing to organ dysfunction. However, emergency departments (EDs) and intensive care units (ICUs) currently lack a rapid workflow for early identification of SIs. Herein, an innovative strategy for early SIs identification is proposed. We construct a portable nanobiosensor based on the Nanozyme-Linked Immunosorbent Assay (NLISA) for ultrasensitive and specific Multi-Cytokines quantification, benefiting from its advantages of parallel, independent, rapid, and portable detection. Machine learning is applied to process Multi-Cytokines concentration data measured under varied conditions and build an early identification model for rapid and effective sepsis immunoparalysis diagnosis. This method achieves point-of-care testing (POCT) with small plasma sample volumes (30 µL), with a detection limit as low as 3.8 fg mL − 1 . Notably, machine learning models constructed from different cytokine combinations can achieve high diagnostic performance, accurately distinguishing sepsis immunoparalysis, sepsis non-immunoparalysis, and healthy donors, while addressing diverse clinical needs and cost-effectiveness considerations, enabling personalized diagnostic strategies tailored to distinct patient populations and resource-constrained settings. This opens up the potential application of the nanobiosensor with machine learning for POCT of Multi-Cytokines detection and sepsis immunoparalysis early identification.
✓ 已验证
产品关联
DOI
高影响因子
Nature Communications
·
2026
·Vol. 17
·期 1
·8260
·
IF 18.1
Li Li,Yang Hang,Yao Tengyu,Zhang Yiming,Tan Yicheng,Miao Chenglin,Chen Duo,Wang Jingyi,Zhong Yunpeng,Guo Xingsen,Feng Jianrui,Hashibon Adham,Li Guangshe,Han Wei,He Guanjie
While additive-induced modulation of solvation structure has emerged as an effective strategy to enhance the performance of aqueous zinc-ion batteries, the electrochemical mechanisms by which non-solvation additives interact with ion species within the electric double layer and their subsequent impact on solid electrolyte interphase evolution remain poorly understood. Here, we propose an anion-released interfacial engineering strategy that leverages the competitive spatial distribution between surface-affinitive anions and cationic regulators within the Stern layer. This competition governs additive accessibility to the interface and enables the construction of a robust, inorganic–organic hybrid interface. Combined with in situ spectra and theoretical simulations, we decouple the key kinetic processes in Zn deposition, revealing that fast Zn 2+ transport within the solid electrolyte interphase, coupled with moderated desolvation at the interface, underpins dendrite-free and highly reversible cycling. This study has the potential to establish a mechanistic framework for the interfacial function of non-solvating additives, thus offering refined insights into electrolyte design and interphase engineering for high-performance aqueous metal batteries.
✓ 已验证
DOI
高影响因子
NATURE MATERIALS
·
2026
·
IF 38
Cao Qiannan,Yao Yingli,Zheng Wenming,Liu Hongqian,Jiang Mingxia,Xie Dayang,Zhang Siting,Su Pijun,Yuan Huilin,Chen Xiaoyuan,Fang Huapan,Tian Huayu
The clinical success of chimeric antigen receptor (CAR) T cell therapy requires scalable, non-invasive strategies for in vivo T cell engineering. Although mRNA delivery offers a promising alternative, lipid-nanoparticle-based carriers show limited efficiency for in vivo T cell transfection and typically require antibody conjugation. Here we report an inherent T cell-activating polymer–lipid nanoparticle that enables ligand-free, efficient mRNA transfection and activation of T cells in vivo. This mRNA delivery vehicle, composed of p -toluenesulfonyl arginine (RT)-modified oligoethylenimine-based lipid nanoparticles (ERTLNPs), preferentially mediated mRNA transfection in the spleen following systemic administration. Without exogenous stimulation, ERTLNPs intrinsically activated T cells, triggering robust mRNA expression and proliferation. Mechanistically, ERTLNPs engaged the PI3K/AKT/mTOR signalling axis to reprogram T cell metabolism, promoting expansion and restraining exhaustion. The systemic delivery of mRNA encoding fibroblast activation protein CAR via ERTLNPs contributed to the in situ generation of functional CAR T cells, which efficiently eliminated pathological fibroblasts in models of cancer and fibrosis, with minimal off-target effects. This ligand-free, metabolically reprogramming mRNA delivery system provides a clinically translatable approach for in vivo CAR T cell generation.
✓ 已验证
产品关联
DOI
高影响因子
MICROCHIMICA ACTA
·
2026
·Vol. 193
·期 9
·614
·
IF 5.4
Xiao Hongping,Wang Xinying,Xue Siqi,Wu Zhongyuan,Huang Rongjun,Fan Min,Chen Yuanmei,Feng Shangyuan
Squamous cell carcinoma antigen (SCCA) a magnetic enrichment–assisted core–satellite surface-enhanced Raman scattering (SERS) biosensor for ultrasensitive squamous cell carcinoma antigen (SCCA) detection is reported. Magnetic nanoparticles functionalized with SCCA capture antibodies act as enrichment cores, while 4-mercaptobenzoic acid (MBA)–encoded Au@Ag core–shell nanoparticles conjugated with SCCA detection antibodies serve as SERS satellites. Target-mediated sandwich immunorecognition induces a dynamically assembled core–satellite structure, bringing plasmonic nanogaps into close proximity and generating reproducible electromagnetic hot spots for signal amplification. Magnetic pre-enrichment and controlled assembly help reduce nonspecific protein interference in serum and contribute to stable signal generation. The biosensor exhibited a monotonic concentration-dependent Raman response over the range of 1 fg/mL to 10¹¹ fg/mL and achieved a limit of detection (LOD) of 60.0 fg/mL. Quantitative determination of serum samples was performed using an independently established matrix-matched calibration curve. The platform was further validated using real human serum samples from early-stage lung SqCC patients ( n = 8) and healthy controls ( n = 8), showing higher SCCA concentrations in patient samples than in healthy controls and clear discrimination between the two groups. Overall, the proposed magnetic enrichment–assisted core–satellite SERS immunoassay provides a robust analytical strategy for sensitive SCCA quantification in complex serum matrices. Graphical abstract
✓ 已验证
产品关联
DOI
高影响因子
Frontiers in Bioscience-Landmark
·
2026
·Vol. 31
·期 8
·
IF 4.1
Yulian Shi,Tingyu Fan,Rongmei Qu,Guosheng Wu,Xiangtian Li,Jiaxuan Liu,Ziyi Feng,Haopeng Wu,Jun Ouyang,Jingxing Dai
Background:
Bone tissue possesses strong regenerative potential, but large segmental bone defects often exceed its intrinsic capacity for self-healing. Human adipose-derived stem cells (hASCs) offer a promising cellular basis for bone regeneration owing to their robust osteogenic differentiation potential. However, the role of PDZ and LIM domain 2 (PDLIM2) play in hASC osteogenesis and its relationship with the Wnt/β-catenin signaling pathway remain poorly understood.
Methods:
Western blotting, immunofluorescence staining, Alizarin Red S staining, alkaline phosphatase activity assays, wound healing assays, and Transwell assays were employed to assess osteogenic differentiation, osteogenic capacity, and cellular migration. Lentivirus-mediated PDLIM2 knockdown, cytochalasin D (CytoD) intervention, microfilament stabilizer treatment, and β-catenin activator treatment were used as a means of validating the regulatory mechanism.
Results:
hASCs exhibited the ability to undergo osteogenic differentiation. During this osteogenic process, significant increases in PDLIM2, β-actin, and β-catenin expression were observed, with PDLIM2 expression reaching 2–3 times that of the control group on day 14, whereas β-actin and β-catenin levels peaked on day 7 (1.5–2 times those in the control group). Lentivirus-mediated PDLIM2 knockdown reduced β-actin expression by approximately 5-fold and β-catenin expression by approximately 1.7-fold, accompanied by cytoskeletal disorganization and impaired osteogenic differentiation. Actin microfilament integrity was found to regulate osteogenic marker expression and alkaline phosphatase activity, while CytoD treatment suppressed β-actin and β-catenin expression to approximately 50% of control levels and inhibited osteogenic differentiation. Knocking down PDLIM2 attenuated the responsiveness of hASCs to microfilament stabilizers and β-catenin activators.
Conclusions:
This study demonstrates that PDLIM2 may be functionally associated with β-catenin nuclear translocation, potentially through the remodeling of the actin cytoskeleton. These findings provide preliminary mechanistic insight and warrant further validation.
Keywords
PDLIM2human adipose-derived stem cells (hASCs)osteogenesiscytoskeletonβ-catenin
✓ 已验证
产品关联
DOI
高影响因子
Journal of Translational Medicine
·
2026
·Vol. 24
·期 1
·1029
·
IF 9.7
Cheng Kai-wen,Zhou Shao-jun,Zeng Jie,Zhang Yang-rui,Jin Bing-qian,Wang Ping,He Ling-yan,Qi Xu-chen,Liu Xu-dong,Yu Lu-shan,Zhang Yan-xing
Background Among tumors affecting the central nervous system (CNS), glioblastoma multiforme (GBM) is the most aggressive and lethal form. Given the complex mechanisms of the CNS and the blood-brain barrier (BBB), effective therapies for GBM remain limited. To identify potential therapeutic candidates for glioma, we developed a small-molecule library to screen for compounds with potent anti-proliferative effects and BBB permeability. The mechanisms underlying their anti-glioma activity were further elucidated to provide insights into new treatment strategies. Methods A library of small molecules was screened to identify agents that significantly inhibit glioma cells activity. The effects of the lead compound (Dihydrotanshinone I, DHT) on glioma progression were evaluated through a series of experimental approaches, including cell counting kit-8 assays, cell cycle analysis, apoptosis detection, wound healing, transwell migration, reactive oxygen measurement, subcutaneous xenograft mouse models, and intracranial orthotopic tumor models. To elucidate the underlying mechanisms, network pharmacology and transcriptomic analyses were employed. The mechanism of DHT in glioma pathogenesis was further validated using bioinformatics analyses and clinical glioma tissue samples. Results Based on pharmacokinetic evaluation, DHT was found to traverse the BBB, indicating its capacity to reach the cerebral parench. In vitro and in vivo experiments demonstrated that DHT significantly suppresses glioma growth and progression. Mechanistic analyses using network pharmacology and RNA sequencing revealed that DHT induces glioma cell apoptosis by inhibiting the Janus kinase-signal transducer and activator of transcription 3 (STAT3) signaling pathway, increasing intracellular reactive oxygen species levels and triggering intrinsic apoptotic cascades. Furthermore, bioinformatic analyses of clinical cohorts coupled with validation in patient-derived glioma specimens confirmed that elevated STAT3 expression was correlated with unfavorable prognosis and was significantly increased in patients with high-grade glioma. Conclusions This study demonstrates that, in addition to its role as a key contributor to glioma malignancy and a prognostic marker, STAT3 is also a target of DHT, highlighting its potential as a promising therapeutic candidate for treating GBM. Graphical
✓ 已验证
DOI
高影响因子